hydroxychloroquine has been researched along with Cryptococcosis in 5 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Cryptococcosis: Fungal infection caused by genus CRYPTOCOCCUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of primary cutaneous cryptococcosis in a patient taking adalimumab, methotrexate, and hydroxychloroquine for rheumatoid arthritis." | 7.74 | Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab. ( Mowad, CM; Sewell, LD; Wilson, ML, 2008) |
| " We report a case of primary cutaneous cryptococcosis in a patient taking adalimumab, methotrexate, and hydroxychloroquine for rheumatoid arthritis." | 3.74 | Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab. ( Mowad, CM; Sewell, LD; Wilson, ML, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 1 |
| Long, X | 1 |
| Jia, S | 1 |
| Zhu, J | 1 |
| Zhou, Z | 1 |
| Ahmed, S | 1 |
| Jiang, Y | 3 |
| Luo, W | 1 |
| Che, D | 1 |
| Lu, H | 1 |
| Narayanan, S | 1 |
| Banerjee, C | 1 |
| Holt, PA | 1 |
| Yong, L | 1 |
| Wilson, ML | 1 |
| Sewell, LD | 1 |
| Mowad, CM | 1 |
5 other studies available for hydroxychloroquine and Cryptococcosis
| Article | Year |
|---|---|
In vitro and in vivo synergistic effects of hydroxychloroquine and itraconazole on Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Hydroxychloroquine; Itraconazol | 2023 |
New Perspectives from Misdiagnosis: A Case of Primary Cutaneous Cryptococcosis Treated with Hydroxychloroquine Sulfate Successfully.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Humans; Hydroxy | 2020 |
Cryptococcal immune reconstitution syndrome during steroid withdrawal treated with hydroxychloroquine.
Topics: Aged; Anti-Inflammatory Agents; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; | 2011 |
Cryptococcal immune reconstitution syndrome in HIV-negative patients.
Topics: Antifungal Agents; Cryptococcosis; Female; Humans; Hydroxychloroquine; Immune Reconstitution Inflamm | 2011 |
Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antirheuma | 2008 |